More about
Nrg1 Fusion-Positive Cancers
News
February 05, 2025
2 min read
Save
Zenocutuzumab exhibits efficacy in NRG1 fusion-positive cancers
Zenocutuzumab exhibited efficacy among patients with NRG1 fusion-positive cancers, according to phase 2 data published in The New England Journal of Medicine.